NCT06227598View on ClinicalTrials.gov

From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2026

Conditions
IBD
Interventions
OTHER

Procedure: Additional biopsies collection

Procedure: Additional biopsies collection We will recruit only subjects (UC, CD and NO-UC/CD) scheduled for the endoscopy and biopsies-collection according to the usual clinical practice. During the endoscopy we will collect 6 additional biopsies.

All Listed Sponsors
lead

Federico II University

OTHER

NCT06227598 - From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD | Biotech Hunter | Biotech Hunter